140
Views
9
CrossRef citations to date
0
Altmetric
Review

Stinging insect allergy: current perspectives on venom immunotherapy

&
Pages 75-86 | Published online: 23 Jul 2015

References

  • TanJWCampbellDEInsect allergy in childrenJ Paediatr Child Health2013499E381E38723586469
  • HoffmanDRDoveDEJacobsonRSAllergens in Hymenoptera venom. XX. Isolation of four allergens from imported fire ant (Solenopsis invicta) venomJ Allergy Clin Immunol1988825 Pt 18188273192865
  • HoffmanDRJacobsonRSAllergens in hymenoptera venom XII: how much protein is in a sting?Ann Allergy19845242762786711914
  • KrishnaMTEwanPWDiwakarLDiagnosis and management of hymenoptera venom allergy: British Society for Allergy and Clinical Immunology (BSACI) guidelinesClin Exp Allergy20114191201122021848758
  • GraftDFSchuberthKCKagey-SobotkaAA prospective study of the natural history of large local reactions after Hymenoptera stings in childrenJ Pediatr198410456646686716215
  • MaurielloPMBardeSHGeorgitisJWReismanRENatural history of large local reactions from stinging insectsJ Allergy Clin Immunol1984744 Pt 14944986491095
  • GoldenDBKellyDHamiltonRGCraigTJVenom immunotherapy reduces large local reactions to insect stingsJ Allergy Clin Immunol200912361371137519443022
  • BilóBMRueffFMosbechHBonifaziFOude-ElberinkJNthe EAACI Interest Group on Insect Venom HypersensitivityDiagnosis of Hymenoptera venom allergyAllergy200560111339134916197464
  • PumphreyRSLessons for management of anaphylaxis from a study of fatal reactionsClin Exp Allergy20003081144115010931122
  • Antolín-AmérigoDMoreno AguilarCVegaAAlvarez-MonMVenom immunotherapy: an updated reviewCurr Allergy Asthma Rep201414744924934908
  • GoldenDBKagey-SobotkaANormanPSHamiltonRGLichtensteinLMOutcomes of allergy to insect stings in children, with and without venom immunotherapyN Engl J Med2004351766867415306668
  • TurnerPJGowlandMHSharmaVIncrease in anaphylaxisrelated hospitalizations but no increase in fatalities: an analysis of United Kingdom national anaphylaxis data, 1992–2012J Allergy Clin Immunol20151354956963.e125468198
  • GraftDFInsect sting allergyMed Clin North Am200690121123216310531
  • BilòMBAnaphylaxis caused by Hymenoptera stings: from epidemiology to treatmentAllergy201166Suppl 95353721668850
  • WormMMoneret-VautrinASchererKFirst European data from the network of severe allergic reactions (NORA)Allergy201469101397140424989080
  • XieCXuSDingFClinical features of severe wasp sting patients with dominantly toxic reaction: analysis of 1091 casesPloS One2013812e8316424391743
  • GoldenDBMoffittJNicklasRAStinging insect hypersensitivity: a practice parameter update 2 011J Allergy Clin Immunol201112748528544.e1e2321458655
  • RuëffFPrzybillaBBilóMBPredictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom HypersensitivityJ Allergy Clin Immunol200912451047105419895993
  • BoyleRJElremeliMHockenhullJVenom immunotherapy for preventing allergic reactions to insect stingsCochrane Database Syst Rev201210CD00883823076950
  • YavuzSTSahinerUMBuyuktiryakiBClinical features of children with venom allergy and risk factors for severe systemic reactionsInt Arch Allergy Immunol2013160331332123095437
  • PucciSDe PasqualeTD’AlòSIlluminatiIMakrìEIncorvaiaCSystemic reactions to honeybee stings and nonsteroidal antinflammatory drugsAnn Allergy Asthma Immunol2014113223723824986037
  • WoodRACamargoCAJrLiebermanPAnaphylaxis in America: the prevalence and characteristics of anaphylaxis in the United StatesJ Allergy Clin Immunol2014133246146724144575
  • BakerTWForesterJPJohnsonMLStolfAStahlMCThe HIT study: Hymenoptera Identification Test – how accurate are people at identifying stinging insects?Ann Allergy Asthma Immunol2014113326727024969241
  • SturmGJKranzelbinderBSchusterCSensitization to Hymenoptera venoms is common, but systemic sting reactions are rareJ Allergy Clin Immunol2014133616351643.e124365141
  • PortnoyJMMoffittJEGoldenDBStinging insect hypersensitivity: a practice parameter. The Joint Force on Practice Parameters, the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and ImmunologyJ Allergy Clin Immunol19991035 Pt 196398010366310
  • StrohmeierBAbererWBokanovicDKomerickiPSturmGJSimultaneous intradermal testing with hymenoptera venoms is safe and more efficient than sequential testingAllergy201368454254423405953
  • TreudlerRSimonJCOverview of component resolved diagnosticsCurr Allergy Asthma Rep201313111011723076421
  • Product Catalog 2012 – ImmunoCAP: Is it allergy?WalthamThermo Fisher Scientific2012 Available from: http://www.phadia.com/Global/A%20Document%20Library/Product%20Catalogues/ProdCat2012_ID_AI.pdfAccessed March 10, 2015
  • ReismanREMüllerURWypychJILazellMIStudies of coexisting honeybee and vespid-venom sensitivityJ Allergy Clin Immunol19847322462526699307
  • MüllerURJohansenNPetersenABFromberg-NielsenJHaeberliGHymenoptera venom allergy: analysis of double positivity to honey bee and Vespula venom by estimation of IgE antibodies to species-specific major allergens Api m1 and Ves v5Allergy200964454354819120073
  • MittermannIZidarnMSilarMRecombinant allergen-based IgE testing to distinguish bee and wasp allergyJ Allergy Clin Immunol2010125613001307.e320466415
  • SpillnerEBlankSJakobTHymenoptera allergens: from venom to “venome”Front Immunol201457724616722
  • KorošecPValentaRMittermannILow sensitivity of commercially available rApi m 1 for diagnosis of honeybee venom allergyJ Allergy Clin Immunol2011128367167321481443
  • SeismannHBlankSCifuentesLRecombinant phospholipase A1 (Ves v 1) from yellow jacket venom for improved diagnosis of hymenoptera venom hypersensitivityClin Mol Allergy20108720359368
  • EberleinBKrischanLDarsowUOllertMRingJDouble positivity to bee and wasp venom: improved diagnostic procedure by recombinant allergen-based IgE testing and basophil activation test including data about cross-reactive carbohydrate determinantsJ Allergy Clin Immunol2012130115516122421265
  • MonsalveRIVegaAMarquésLComponent-resolved diagnosis of vespid venom-allergic individuals: phospholipases and antigen 5s are necessary to identify Vespula or Polistes sensitizationAllergy201267452853622229815
  • SantosAFDu ToitGDouiriADistinct parameters of the basophil activation test refect the severity and threshold of allergic reactions to peanutJ Allergy Clin Immunol201513511798625567046
  • SantosAFDouiriABécaresNBasophil activation test discriminates between allergy and tolerance in peanut-sensitized childrenJ Allergy Clin Immunol2014134364565225065721
  • BonadonnaPZanottiRMelioliGThe role of basophil activation test in special populations with mastocytosis and reactions to hymenoptera stingAllergy201267796296522676063
  • González-de-OlanoDAlvarez-TwoseIMorgadoJMEvaluation of basophil activation in mastocytosis with Hymenoptera venom anaphylaxisCytometry B Clin Cytom201180316717521520404
  • Working Group of the Resuscitation Council (UK)Emergency Treatment of Anaphylactic Reactions. Guidelines for Healthcare ProvidersLondonResuscitation Council (UK)2008 Available from: http://www.resus.org.uk/pages/reaction.pdfAccessed March 10, 2015
  • MuraroARobertsGWormMAnaphylaxis: guidelines from the European Academy of Allergy and Clinical ImmunologyAllergy20146981026104524909803
  • PumphreyRSHFatal posture in anaphylactic shockJ Allergy Clin Immunol2003112245145212897756
  • BrownSGBlackmanKEStenlakeVHeddleRJInsect sting anaphylaxis; prospective evaluation of treatment with intravenous adrenaline and volume resuscitationEmerg Med J200421214915414988337
  • SmithPLKagey-SobotkaABleeckerERPhysiologic manifestations of human anaphylaxisJ Clin Invest1980665107210806776143
  • VisscherPKVetterRSCamazineSRemoving bee stingsLancet199634890233013028709689
  • HowdlePNICEclinical guideline 1 34. Anaphylaxis: assessment to confirm an anaphylactic episode and the decision to refer after emergency treatment for a suspected anaphylactic episode [webpage on the Internet]LondonNational Institute for Health and Care Excellence2011 Available from: http://www.nice.org.uk/guidance/CG134Accessed March 10, 2015
  • Oude ElberinkJNDe MonchyJGVan Der HeideSGuyattGHDuboisAEVenom immunotherapy improves health-related quality of life in patients allergic to yellow jacket venomJ Allergy Clin Immunol2002110117418212110838
  • NoonLProphylactic inoculation against hay feverLancet1911177458015721573
  • FranklandAWAugustinRProphylaxis of summer hay-fever and asthma: a controlled trial comparing crude grass-pollen extracts with the isolated main protein componentLancet195426668211055105713164324
  • BraunLNotes on desensitisation of a patient hypersensitive to bee stingsSouth Afr Med Rec192523408409
  • JutelMAkdisCAImmunological mechanisms of allergen-specific immunotherapyAllergy201166672573221466562
  • HuntKJValentineMDSobotkaAKBentonAWAmodioFJLichtensteinLMA controlled trial of immunotherapy in insect hypersensitivityN Engl J Med1978299415716178446
  • DurhamSRWalkerSMVargaEMLong-term clinical efficacy of grass-pollen immunotherapyN Engl J Med1999341746847510441602
  • EwanPWNew insight into immunological mechanisms of venom immunotherapyCurr Opin Allergy Clin Immunol20011436737411964715
  • AkdisMAkdisCAMechanisms of allergen-specific immunotherapyJ Allergy Clin Immunol2007119478079117321578
  • HayashiYHirataHWatanabeMUsefulness of specific-IgG4 to Hymenoptera venom in the natural history of hymenoptera stingsJ Investig Allergol Clin Immunol2014243192194
  • CoxLNelsonHLockeyRAllergen immunotherapy: a practice parameter third updateJ Allergy Clin Immunol20111271 SupplS1S5521122901
  • GoldbergAConfino-CohenRBee venom immunotherapy – how early is it effective?Allergy201065339139519839973
  • BrownSGWieseMDvan EedenPUltrarush versus semirush initiation of insect venom immunotherapy: a randomized controlled trialJ Allergy Clin Immunol2012130116216822460067
  • BrehlerRWolfHKüttingBSchnitkerJLugerTSafety of a two-day ultrarush insect venom immunotherapy protocol in comparison with protocols of longer duration and involving a larger number of injectionsJ Allergy Clin Immunol20001056 Pt 11231123510856159
  • BirnbaumJCharpinDVervloetDRapid Hymenoptera venom immunotherapy: comparative safety of three protocolsClin Exp Allergy19932332262308472191
  • KöhlerJBlankSMüllerSComponent resolution reveals additional major allergens in patients with honeybee venom allergyJ Allergy Clin Immunol20141335138313891389. e1e624440283
  • GoldenDBNew directions in diagnostic evaluation of insect allergyCurr Opin Allergy Clin Immunol201414433433924915545
  • KonstantinouGNManoussakisEDouladirisNA 5-year venom immunotherapy protocol with 50 µg maintenance dose: safety and efficacy in school childrenPediatr Allergy Immunol201122439339721235631
  • SimioniLVianelloABonadonnaPEfficacy of venom immunotherapy given every 3 or 4 months: a prospective comparison with the conventional regimenAnn Allergy Asthma Immunol20131101515423244659
  • GoldbergAConfino-CohenRRush venom immunotherapy in patients experiencing recurrent systemic reactions to conventional venom immunotherapyAnn Allergy Asthma Immunol200391440541014582821
  • RuëffFWenderothAPrzybillaBPatients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom dosesJ Allergy Clin Immunol200110861027103211742283
  • AdlerAPharmalgen for the Treatment of Bee and Wasp Venom Allergy: Technology Appraisal Guidance [TA246] [webpage on the Internet]LondonNational Institute for Health and Care Excellence2012 [cited January 27, 2015]. Available from: https://www.nice.org.uk/guidance/ta246Accessed March 10, 2015
  • HockenhullJElremeliMCherryMGA systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen® for the treatment of bee and wasp venom allergyHealth Technol Assess20121612IIIIV111022409877
  • GoldenDBKagey-SobotkaALichtensteinLMSurvey of patients after discontinuing venom immunotherapyJ Allergy Clin Immunol20001052 Pt 138539010669863
  • PeterneljASilarMErzenRKosnikMKorosecPBasophil sensitivity in patients not responding to venom immunotherapyInt Arch Allergy Immunol2008146324825418270492
  • Oude ElberinkJNde MonchyJGGoldenDBBrouwerJLGuyattGHDuboisAEDevelopment and validation of a health-related quality-of-life questionnaire in patients with yellow jacket allergyJ Allergy Clin Immunol2002109116217011799384
  • Oude ElberinkJNvan der HeideSGuyattGHDuboisAEImmunotherapy improves health-related quality of life of adult patients with dermal reactions following yellow jacket stingsClin Exp Allergy200939688388919364334
  • KoschelDSSchmiesMWeberCNHöffkenGBalckFTolerated sting challenge in patients on Hymenoptera venom immunotherapy improves health-related quality of lifeJ Investig Allergol Clin Immunol2014244226230
  • FischerJTeufelMFeidtAGielKEZipfelSBiedermannTTolerated wasp sting challenge improves health-related quality of life in patients allergic to wasp venomJ Allergy Clin Immunol2013132248949023639308
  • YavuzSTSahinerUMBuyuktiryakiBPD41 – Risk factors for side effects during venom immunotherapy in children with hymenoptera venom allergyClin Transl Allergy20144P41
  • RuëffFPrzybillaBBilóMBPredictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: the importance of baseline serum tryptaseJ Allergy Clin Immunol20101261105111.e520542320
  • RuëffFPrzybillaBBilóMBClinical effectiveness of hymenoptera venom immunotherapy: a prospective observational multicenter study of the European academy of allergology and clinical immunology interest group on insect venom hypersensitivityPLoS One201385e6323323700415
  • LerchEMüllerURLong-term protection after stopping venom immunotherapy: results of re-stings in 200 patientsJ Allergy Clin Immunol199810156066129600496
  • MüllerUHelblingABerchtoldEImmunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safetyJ Allergy Clin Immunol19928925295351740583
  • RuëffFPrzybillaBMüllerUMosbechHThe sting challenge test in Hymenoptera venom allergy. Position paper of the Subcommittee on Insect Venom Allergy of the European Academy of Allergology and Clinical ImmunologyAllergy19965142162258792917
  • BerchtoldEMaibachRMüllerUReduction of side effects from rush-immunotherapy with honey bee venom by pretreatment with terfenadineClin Exp Allergy199222159651551035
  • MüllerUHariYBerchtoldEPremedication with antihistamines may enhance efficacy of specific-allergen immunotherapyJ Allergy Clin Immunol20011071818611149995
  • BrockowKKiehnMRiethmüllerCVielufDBergerJRingJEfficacy of antihistamine pretreatment in the prevention of adverse reactions to Hymenoptera immunotherapy: a prospective, randomized, placebo-controlled trialJ Allergy Clin Immunol199710044584639338537
  • NiedoszytkoMGruchała-NiedoszytkoMJassemEGene expression analysis in allergology: the prediction of Hymenoptera venom allergy severity and treatment efficacyClin Transl Allergy2013313524160178
  • BoyleRJDicksonRHockenhullJCherryMGElremeliMImmunotherapy for Hymenoptera venom allergy: too expensive for European health care?Allergy201368101341134224134604
  • GaleraCSoohunNZankarNCaimmiSGallenCDemolyPSevere anaphylaxis to bee venom immunotherapy: efficacy of pretreatment and concurrent treatment with omalizumabJ Investig Allergol Clin Immunol2009193225229
  • PalganKBartuziZGotz-ZbikowskaMTreatment with a combination of omalizumab and specific immunotherapy for severe anaphylaxis after a wasp stingInt J Immunopathol Pharmacol201427110911224674685
  • CoxLCompalatiEKundigTLarcheMNew directions in immunotherapyCurr Allergy Asthma Rep201313217819523315329
  • PatriarcaGNuceraERoncalloCSublingual desensitization in patients with wasp venom allergy: preliminary resultsInt J Immunopathol Pharmacol200821366967718831935
  • SeverinoMGCortelliniGBonadonnaPSublingual immunotherapy for large local reactions caused by honeybee sting: a double-blind, placebo-controlled trialJ Allergy Clin Immunol20081221444818468672
  • FellrathJMKettnerADufourNAllergen-specific T-cell tolerance induction with allergen-derived long synthetic peptides: results of a phase I trialJ Allergy Clin Immunol2003111485486112704369
  • TarziMKlunkerSTexierCInduction of interleukin-10 and suppressor of cytokine signalling-3 gene expression following peptide immunotherapyClin Exp Allergy200636446547416630151
  • KeatingMUKagey-SobotkaAHamiltonRGYungingerJWClinical and immunologic follow-up of patients who stop venom immunotherapyJ Allergy Clin Immunol1991883 Pt 13393481890261
  • GoldenDBFatal insect allergy after discontinuation of venom immunotherapyJ Allergy Clin Immunol2001107592592611344366
  • EboDGVan VaerenberghMde GraafDCBridtsCHDe ClerckLSSabatoVIn vitro diagnosis of Hymenoptera venom allergy and further development of component resolved diagnosticsExpert Rev Clin Immunol201410337538424490811